cjtrdng Message Board - Msg: 16535429

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : cjtrdng

GE 308.70

-0.1%

9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

To: 249443 who started this subject	10/21/2001 12:28:16 PM
From: 249443	of 7

Jim McCamant is generally viewed as one of the nation's foremost experts on biotechnology and pharmaceutical stocks. He is the founder of the Medical Technology Stock Letter (MTSL) which has analyzed developments and investment opportunities in biotechnology biweekly since 1983. The media and biotechnology industry observers closely follow his views in MTSL. McCamant has a 40-year record in the investment industry, including stints as a broker and investment analyst in San Francisco, and he was founder and principal of two brokerage firms. McCamant's stock recommendations appear in Worth magazine's regular monthly "What They're Recommending" section. The Medical Technology Stock Letter PO Box 40460 Berkeley,Ca. 94704 Phone: 510-843-1857. Medical

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext